BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26825095)

  • 1. Urinary Metabolomics Reveals Alterations of Aromatic Amino Acid Metabolism of Alzheimer's Disease in the Transgenic CRND8 Mice.
    Tang Z; Liu L; Li Y; Dong J; Li M; Huang J; Lin S; Cai Z
    Curr Alzheimer Res; 2016; 13(7):764-76. PubMed ID: 26825095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
    Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2395-402. PubMed ID: 25281826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Throughput Metabolomics for Discovering Potential Metabolite Biomarkers and Metabolic Mechanism from the APPswe/PS1dE9 Transgenic Model of Alzheimer's Disease.
    Yu J; Kong L; Zhang A; Han Y; Liu Z; Sun H; Liu L; Wang X
    J Proteome Res; 2017 Sep; 16(9):3219-3228. PubMed ID: 28753016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Candidate Urine Biomarkers for Detecting Alzheimer's Disease Before Amyloid-β Plaque Deposition in an APP (swe)/PSEN1dE9 Transgenic Mouse Model.
    Zhang F; Wei J; Li X; Ma C; Gao Y
    J Alzheimers Dis; 2018; 66(2):613-637. PubMed ID: 30320578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampal metabolomics using ultrahigh-resolution mass spectrometry reveals neuroinflammation from Alzheimer's disease in CRND8 mice.
    Lin S; Liu H; Kanawati B; Liu L; Dong J; Li M; Huang J; Schmitt-Kopplin P; Cai Z
    Anal Bioanal Chem; 2013 Jun; 405(15):5105-17. PubMed ID: 23494273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering metabolic abnormalities associated with Alzheimer's disease in the APP/PS1 mouse model using integrated metabolomic approaches.
    González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
    Biochimie; 2015 Mar; 110():119-128. PubMed ID: 25597416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrahigh resolution mass spectrometry-based metabolic characterization reveals cerebellum as a disturbed region in two animal models.
    Lin S; Kanawati B; Liu L; Witting M; Li M; Huang J; Schmitt-Kopplin P; Cai Z
    Talanta; 2014 Jan; 118():45-53. PubMed ID: 24274269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary and faecal metabolic characteristics in APP/PS1 transgenic mouse model of Alzheimer's disease with and without cognitive decline.
    Zheng Y; Xu Q; Jin Q; Du Y; Yan J; Gao H; Zheng H
    Biochem Biophys Res Commun; 2022 May; 604():130-136. PubMed ID: 35303679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of isotope labeling liquid chromatography mass spectrometry for mouse urine metabolomics: quantitative metabolomic study of transgenic mice related to Alzheimer's disease.
    Peng J; Guo K; Xia J; Zhou J; Yang J; Westaway D; Wishart DS; Li L
    J Proteome Res; 2014 Oct; 13(10):4457-69. PubMed ID: 25164377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomic screening of regional brain alterations in the APP/PS1 transgenic model of Alzheimer's disease by direct infusion mass spectrometry.
    González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
    J Pharm Biomed Anal; 2015 Jan; 102():425-35. PubMed ID: 25459942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Hair Metabolome in 5xFAD Mice and Patients with Alzheimer's Disease Using Mass Spectrometry-Based Metabolomics.
    Chang CW; Hsu JY; Lo YT; Liu YH; Mee-Inta O; Lee HT; Kuo YM; Liao PC
    ACS Chem Neurosci; 2024 Feb; 15(3):527-538. PubMed ID: 38269400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic investigation of systemic manifestations associated with Alzheimer's disease in the APP/PS1 transgenic mouse model.
    González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
    Mol Biosyst; 2015 Sep; 11(9):2429-40. PubMed ID: 26131452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences of peripheral plasma and liver metabolic profiling in APP/PS1 transgenic AD mice.
    Wu J; Fu B; Lei H; Tang H; Wang Y
    Neuroscience; 2016 Sep; 332():160-9. PubMed ID: 27393253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomics profiling reveals distinct, sex-specific signatures in serum and brain metabolomes in mouse models of Alzheimer's disease.
    Pandey RS; Arnold M; Batra R; Krumsiek J; Kotredes KP; Garceau D; Williams H; Sasner M; Howell GR; Kaddurah-Daouk R; Carter GW
    Alzheimers Dement; 2024 Jun; 20(6):3987-4001. PubMed ID: 38676929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A metabolomic study of the CRND8 transgenic mouse model of Alzheimer's disease.
    Salek RM; Xia J; Innes A; Sweatman BC; Adalbert R; Randle S; McGowan E; Emson PC; Griffin JL
    Neurochem Int; 2010 Jul; 56(8):937-47. PubMed ID: 20398713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabonomic profiling of TASTPM transgenic Alzheimer's disease mouse model.
    Hu ZP; Browne ER; Liu T; Angel TE; Ho PC; Chan EC
    J Proteome Res; 2012 Dec; 11(12):5903-13. PubMed ID: 23078235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.
    Adegoke OO; Qiao F; Liu Y; Longley K; Feng S; Wang H
    J Alzheimers Dis; 2017; 59(2):575-590. PubMed ID: 28598849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Traumatic Brain Injury Alters the Metabolism and Facilitates Alzheimer's Disease in a Murine Model.
    Lou D; Du Y; Huang D; Cai F; Zhang Y; Li T; Zhou W; Gao H; Song W
    Mol Neurobiol; 2018 Jun; 55(6):4928-4939. PubMed ID: 28776265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
    Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
    J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.